Antimicrobial Agents and Chemotherapy

It’s vital to optimize use of antimicrobials Optimize antimicrobial use to confirm effectiveness whereas minimizing resistance development in common community-acquired infections Identify management ways to stop, or minimize clinically important drug interactions with common antimicrobials. Safety and effectiveness of intravenous iron in patients with chemotherapy- elicited anemia receiving darbepoetin alfa Effects of endovenous (IV) iron supplementation on responses to every-three-week (Q3W) darbepoetin alfa (DA) by baseline hemoglobin in patients (pts) with chemotherapy-induced anemia (CIA)1 A phase III clinical trial randomised controlled study comparison iron saccharose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing therapy and glycoprotein stimulating agent (ESA) therapy Improvement in quality of life precedes increase in hemoglobin levels upon treatment with intravenous iron and epoetin alfa.

  • Antimicrobials, diagnostics and infection control

Related Conference of Antimicrobial Agents and Chemotherapy

November 21-22, 2024

7th Pathology and Infectious Disease Conference

Dubai, UAE
November 28-29, 2024

20th World Congress on Infection Prevention and Control

Paris, France
March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands

Antimicrobial Agents and Chemotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in